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THE SEMISOLID AGAR culture system for growing colonies of mouse granulocytes and/or macrophages has been modified to support the growth of equivalent human cells (1, 2) . In particular, leukemic cells from patients with acute or chronic myeloid leukemia proliferate in agar as either clusters or colonies in which some cell differentiation occurs (3) (4) (5) (6) (7) (8) . Karyotypic studies showed that such clusters and colonies are generated by leukemic cells which are representative of the leukemic cell population in the patient (7, 9, 10) .
The cells in animals and man which initiate granulocytic colony formation in vitro have been characterized as the specific progenitors of granulocytes and monocytic cells. In the monkey, we have made progress in purifying and characterizing these progenitor cells (11, 12) . Because of the general similarity between normal and leukemic colonies, we can assume that the leukemic cells initiating in vitro colonies are neoplastic equivalents of normal colony-forming cells (CFC's) and it is pertinent to determine the frequency and nature of these progenitor cells in leukemic patients.
This report gives results of studies undertaken to analyze the frequency, properties, and growth characteristics of leukemic CFC's and to determine how much these cells differ from normal CFC's.
MATERIALS AND METHODS
Source if material.-Bone marrow was obtained from sternal and posterior iliac crest aspirates taken during hematologic assessment of the clinical status of patients with a variety of myeloproliferative and Iymphoproliferative disorders. We also got marrow and peripheral blood samples from normal volunteers or patients with non myeloid hematologic disorders. Marrow samples were collected in preservative-free heparin and either allowed to stand at 4° C for I hour before the supernatant leukocyte-rich plasma was collected or centrifuged for 3-5 minutes at 500 Xg, and the huffy coat was removed with a fine pasteur pipette. Leukocytes were then washed thrice in Eisen's balanced salt solution (BSS) before they were counted in a hemocytometer. All cell counts were based on total viable nucleated cells, and no correction factors were applied to eliminate nondividing cells, e.g., metamyelocytes or polymorphs.
Marrow or peripheral blood samples were obtained once or more from 133 patients. Of these, 17 had chronic myeloid leukemia (CML) or chronic myelomonocytic leukemia (CMML) in various clinical stages; 33 had acute myeloid leukemia (AML), acute myelomonocytic leukemia (AMML), or subacute myeloid leukemia (subAML) and were studied before treatment, during relapse, while undergoing treatment, and in remission. Patients were classified as being either in relapse or in partial or complete remission on clinical or hematologic grounds; the criteria were those of Bisel (13) for acute leukemia and of Tjio et al. (14) for CML.
In vitro culture system.-The semisolid agar culture medium consisted of 0.3 % agar in Eagle's minimal essential medium containing 10% fetal calf serum and 5% horse serum, supplemented with trypticase soy broth, asparagine, and dextran. Marrow cells or peripheral blood leukocytes (10 3 _2 X 10 5 ) were cultured in I m1 medium in 35-mm petri dishes either without an exogenous source of colony-stimulating factor (CSF) or with a source ofstimdus provided by I-ml feeder layers containing I X!06 peripheral blood leukccytes obtained from normal subjects, patients with hemochromatosis, or from pooled rhesus monkey blood. The characteristics and details of preparation of such feeder layers were repOrted in (2, 11) . Cultures were kept at 37° C in humidified incubators in 10% CO 2 in air. Control mouse bone marrow cultures came from 3-month-cld C57BL mice. Femoral cells were cultured in a I-ml single layer system. Each culture contained 5 X 10 3 or 5 X 10 4 bone marrow cells, and colony formation was stimulated by inclusion in the medium of O. I m1 of a I : 6 dilution of a serum pool from C57BL mice given 5 "g endotoxin 3 hours earlier. Such serum pools contain high concentratiol11 of CSF.
Ana(ysis if culture.I.-Cultures were scored under a dissecting microscope at X25 and clusters (3-40 cells) were scored at X 40. Standard estimates of colony and cluster incidence were done on day 8 of incubation in cultures containing 2 X!05 nucleated cells. With AML and CML cell cultures where too many cell aggregates developed, valid estimates of true incidence were obtained only in cultures containing lower concentrations of cells; colony confluence with associated problems of inhibition and dispersion prevented accurate counts at higher cell concentrations. Standard estimates of the incidence of spontaneous colonies came ffOm unstimulated cultures containing 2X!05 cells. In certain experiments, total incidence of cluster-forming cells was estimated at earlier stages of culture (days [4] [5] , where the peak incidence of cluster formation occurs.
For the detailed sequential analysis of colony formation, cultures were scored daily from days 1-8 of the incubation period; all discrete aggregates of 3 or more cells were counted. For the detailed size distribution analysis of day-8 cultures, colonies and clusters were removed from these cultures with a fine pasteur pipette. Where total aggregate counts were S250 per culture, all aggregates were taken. With cultures containing larger numbers of aggregates a sequential sample of 150-300 colonies or clusters was removed. Individual colonies or clusters, with a small volume of surrounding agar, were placed on marked squares on microscope slides and allowed to dry. Coverslips were put over the dried colonies and 0.6% orcein in 60% acetic acid was run under the coverslip. The wet preparations were scored at X 400 with all cells in every colony or cluster counted.
Except for occasional colonies in cultures of CML cells, all clusters and colonies were composed entirely of granulocytic cells and in this study no detailed morphologic classification of these cells was attempted. Differentiation in these leukemic cultures seemed somewhat abnormal, particularly in cultures of AML cells; although clearexamples of metamyelocytes and polymorphs were common, the unspread orcein-stained preparations were not uniform enough for accurate cytologic typing.
Buoyant density separation if marrow and peripheral blood
eells.-The detailed technique of buoyant density separation of CFC's with continuous bovine serum albumin (BSA) density gradients or density "cut" procedures has been reported in (2, 11, 15) . Between 101-10 9 cells suspended in a continuous gradient of BSA (osmolarity 269 miIIiosmoles, pH 5.1) were centrifuged at 4000 Xg for 30 minutes. Between 15 and 30 fractions were obtained from the gradient and after precise density estimation, cells were recovered, counted, and cultured for enumeration of both colony-and cluster-forming ceJl incidence. The density distribution profiles of total nucleated cells, CFC's, and cluster-forming cells were determined with the cells per density increment plotted against fraction density, and the peak values were normalized to 100% in each profile, regardless of the absolute numbers. The efficiency of recovery of total nucleated cells from the above density gradients averaged 90% and of CFC's, 110%. The maximum enrichment factor for CFC's was low (maximum 20-fold), since the region of peak incidence of CFC's overlapped the peak distribution of total nucleated cells.
The layer with the cells was overlaid with BSA of lower density to prevent a cell-air interface from forming during centrifugation. The light density « 1.062) supernatant fraction and the cell pellet (> 1.062) were recovered, washed, and cultured.
The number of cells was determined with a hemocytometer or a model B Coulter cell counter with 100/L aperture.
Thymidine suiciding.-Thymidine suiciding was performed with an adaptation of the technique of Iscove et al. (16, 17) . Samples (I m!) of 5 X 10 6 cells suspended in Eisen's BSS were added to I ml of Eisen's BSS containing 40 /LCi tritiated thymidine (3H-TDR) (23 Ci(mM, Amersham, England). Control samples were added to Eisen's BSS. All suspensions were incubated for 30 minutes at 37° C, then washed twice with IO-ml volumes of ice-cold Eisen's BSS containing 100 /Lg(ml unlabeled thymidine and 10% fetal calf serum. Each suicided and control suspension was then cultured in 8 replicate cultures of I ml overlays containing I X 105 cells on underlayers of I X 106 human or monkey peripheral blood cells. In each experiment, bone marrow cells from 3-month-old C57BL mice were suicided as a control for the activity of 3H-TDR. Mouse cells were grown in 6 replicate cultures containing I X 10 4 cells stimulated by 0.1 ml C57BL serum from endotoxin-treated mice. Colony and cluster counts were performed on day 7 of incubation. In some experiments 100 /Lg unlabeled thymidine was added to each culture dish to minimize the possibility of reutilization of lethal or sterilizing doses of 3H-TDR from disintegrating labeled cells. In no case did the addition of unlabeled thymidine alter the results obtained with the original technique.
Morphologic studies.-Smears of marrow or peripheral blood were stained with Wright's. Cell suspensions from density gradient fractions were centrifuged through fetal calf serum in siliconized glass tubes; then the cell pellet was resuspended in serum and smeared on glass slides, and the preparations were fixed in methanol and stained with Giemsa. Differential counts were performed on at least 200 cells.
RESULTS

General PaHern of Colony Formation
In the initial stages (day 0-4), stimulated cultures of normal human bone marrow or peripheral blood cells behaved as did mouse bone marrow cultures, as reported in (J 8). Small, tight aggregates of 3-10 cells developed and the number of such discrete aggregates increased progressively with time. Some aggregates grew progressively and became the major ones, ultimately scored as colonies, but most remained small and many never grew beyond the minimum size of 3 cells (the lower limit for classification as a cluster). VOL. 50, NO.3, MARCH 1973 By 8 days of incubation, the normal human bone marrow cultures resembled the cultures of mouse bone marrow cells stimulated by endotoxin serum, except that colony size was considerably smaller (40-400 cells) than that of corresponding mouse colonies (100-2,000 cells). A difference between the 2 types of cultures was the presence in human cell cultures of many single cells in the background between colonies or clusters. Most of these were well-differentiated granulocytes, though some were macrophages.
When total aggregates were counted on cultures of 5,000 mouse bone marrow cells stimulated by endotoxin serum, the total number of aggregates rose linearly with time to a maximum number at 5-7 days; for the next 7 days of incubation, this number remained constant. In cultures of normal or leukemic human cells the total number of aggregates rose progressively until days 4-5 of incubation, but thereafter total aggregate numbers usually fell sharply so that, by day 10, only 10-50% of those present at days 4-5 of incubation remained in the culture plates (text- fig. 1 ). Classification of aggregates as "colonies" is difficult at 4-5 days of incubation and we cannot be sure whether colony numbers also declined later; sequential observations on cultures from days 7-21 of incubation showed that colony numbers reduced slowly over this period, even though many colonies continued to grow.
We found 2 general reasons for the fall in total aggregate numbers in human cultures. In cultures 
CML-PERIPHERAL BlOOD
Pattern of Colony Formation in Normal Cultures
Analysis was done at day 8 of incubation of cultures of bone marrow cells from patients with minor disturbances in hematopoiesis, e.g., mild iron-deficiency anemia or without known hematologic disease. A typical size distribution pattern of clusters and colonies from such a cultured marrow is shown in text-figure 2, which includes for comparison a culture of mouse bone marrow cells analyzed at day 7 of incubation. Both types of culture have an essentially similar distribution of aggregates, though human cultures often lack the relatively large number of small clusters seen in mouse cultures. Based on these total plate analyses, a minimum of 40 cells was selected as the lower limit for classification of an aggregate as a colony at day 8 of incubation. This minimum agreed well with data obtained independently through colony counts done at X25 before colonies were removed and total cell numbers determined.
The incidence of in vitro CFC's and clusterforming cells in normal human marrow and marrow from patients with a variety of non leukemic hematopoietic disorders is shown in table 1. Colony incidence varied over a 7-fold range in normal subjects and over a 50-fold range in patients with various non leukemic hematopoietic disorders, but the mean colony incidence in the various ~groups stimulated cultures containing 2 X 10 5 marrow cells/ml.
In cultures of peripheral blood leukocytes from 35 normal subjects and patients with mild irondeficiency anemia, colony incidence was 0.5 ± 0.2/ 2 X 10 5 cells and total cluster-forming cells 3 ± 1/ 2 X 10 5 • The incidence of CFC's was higher in some patients with infections and in certain patients with myeloproliferative disorders such as polycythemia vera, megakaryocytic myelosis, erythemic myelosis, and in patients with leukoerythroblastic anemia (where up to a 50-fold increase in circulating CFC's was found).
Culture of Marrow and Peripheral Blood From Patients With Lymphoproliferative Disorders
The in vitro growth characteristics of marrow and peripheral blood from patients with various lymphoproliferative disorders are shown in table 2. Where colonies and clusters formed on culture of marrow or peripheral blood, the colonies always seemed normal in size range and granulocytic in type. No evidence of lymphocyte or plasma cell colonies was obtained. When compared with the CFC incidence in normal subjects or in those patients reported in table 1, patients with ALL in relapse, CLL, and multiple myeloma had greatly reduced levels of CFC's in the marrow associated with extensive infiltration of marrow by lymphoblasts, lymphocytes, or plasma cells. Reduced colony incidence was also evident in cultures of VOL. 50) NO. 3, MARCH 1973 marrow from some patients with Hodgkin's disease with extensive marrow involvement; in other Hodgkin's patients and patients with lymphosarcoma or ALL in remission, colony incidence was within the normal range. Circulating CFC's were rare or undetectable in most patients with lymphoproliferative disorders. However, in 1 patient with ALL and in 1 with lymphosarcoma, incidences of CFC's increased in the circulation (24 and 58/ 2 X 10 5 cells). These circulating CFC's had normal growth and granulocytic differentiation.
Pattern of Colony Formation in Cultures From Patients With AML
Cultures were analyzed from the peripheral blood or bone marrow of 17 patients with AML. In 8 cases, no colony or cluster formation was observed and analysis of these cultures from day 1 onward indicated that never in the incubation period did a single cluster develop (table 3) . This failure of cells to grow in vitro was not the consequence of chemotherapy, since only 1 patient was under treatment when the samples were taken. Six patients had high levels of blast cells in the blood and marrow apparently identical in morphology to blast cells from other patients which did grow well in vitro.
In sharp contrast to the failure of some AML cells to grow in vitro, peripheral blood or marrow cells from 8 of the remaining patients produced large numbers of proliferating aggregates in the but in the rest, many clusters developed in unstimulated cultures, though cluster size was always smaller than in stimulated cultures.
Although cellular differentiation occurred in AML aggregates, it was usually abnormal in that the nuclear morphology of metamyelocytes and polymorphs was bizarre and did not always parallel cytoplasmic differentiation. Furthermore, granule formation in these cells was usually incomplete or nonexistent.
One patient (McK) was atypical in that only a few cluster-forming cells were present in peripheral blood and marrow, and CFC's were found in low numbers in peripheral blood but not in marrow. Most of the blast cell population in this patient was thus incapable of proliferating in agar culture. Possibly the few normally differentiating colonies were produced by surviving normal CFC's displaced from the marrow by a leukemic blast cell population which had lost the capacity to proliferate in vitro.
Where growth occurred in cultures of marrow and peripheral blood from patients with AML, the incidence of cluster-forming cells ranged from O.5~43.5% of all nucleated cells. Cluster-forming cells were generally frequent in peripheral blood as well as in marrow, but in patients with aleukemic leukemia or on chemotherapy, clusterforming cells might be absent in peripheral blood yet present in greatly increased numbers in marrow (table 3) .
Five patients were studied in the untreated or relapse phase of AMML (table 4) aggregates developed initially in comparison with cultures of normal or AML cells and, although cluster numbers slowly increased with time, the cultures of AMML cells were notable for the extensive loss of clusters by cell death. This gave a characteristic background of indistinct debris and made it difficult to identify the few surviving cell clusters. Cells from 2 patients formed relatively large numbers of cell clusters of the same general type as seen in cultures of AML cells and, with 1 patient, some clusters were large enough to be scored as colonies at 8 days, but these colonies failed to show progressive growth and were on average smaller than normal.
No in vitro growth was observed in marrow or peripheral blood cultures established from 2 of the 4 patients with subAML (table 4) . However, in the other 2 patients, both colonies and clusters formed in marrow or peripheral blood cultures. Colony size, morphology, and cluster-to-colony ratios were within the normal range in the 2 cases of subAML where growth occurred.
In Vitro Colony Formation in Remission
Remission was associated with reappearance of colonies exhibiting a normal growth pattern (text- fig. 4 ) and return of a normal colony-tocluster ratio in patients with AML or AMML who had previously shown either complete growth failure or excessive cluster formation in relapse. In the early stages of remission, colony incidence remained low, but in complete remission incidence of colonies and clusters was normal (table 4) .
Paffern of Colony Formation in Cultures From Patients With CML and CMML
Cultures were established on a number of occasions from peripheral blood or bone marrow cells of 13 patients with CML and 4 with CMML; stimulated and unstimulated cultures from the CML patients and 3 CMML patients were examined in detail by aggregate size analysis. 
AML-BONE MARROW -REMISSION
Text- figure 5 shows cell aggregates in cultures of a CML marrow at day 8 of incubation. In general, the size distribution of aggregates and the gross morphology of the aggregates were remarkably similar to those in cultures of normal bone marrow cells. Cultures from both types of patients tended to have a higher proportion of colonies relative to total aggregate numbers than did cultures from nonleukemic patients. Cultures of blood cells from patients with high peripheral white cell levels were essentially identical to those from bone marrow. The pattern of cell growth in cultures from patients on Myleran therapy was not distinguishable from that in cultures of pretreatment cells. Previous analysis of this patient indicated that the leukemic cells were karyotypically abnormal, but analysis of remission colonies indicated a normal karyotype.
In contrast to the sequence in normal cultures, macrophages were seen in many colonies growing from chronic granulocytic leukemic material as early as the 7th-8th day of the incubation period, and this premature macrophage transformation was not observed in cultures from other types of leukemia or hematologic disease. Granulocytic cells matured to morphologically normal metamyelocytes and polymorphs in both colonies and clusters.
The striking abnormality seen in CML patients in the relapse phase was the greatly elevated incidence of both CFC's and cluster-forming cells in the peripheral blood (up to a 50,000-to 60,000-fold absolute increase) and to a lesser extent in the marrow (see table 5 ). When peripheral blood and bone marrow cells were cultured simultaneously, the incidence of CFC's was always higher in the peripheral blood; consequently most analyses were performed solely on peripheral blood samples. In patient Ap with typical CML in the pretreatment phase, CFC-and cluster-forming cell incidence in the marrow was within the normal range, despite an approximately 500-fold increase in CFC incidence in the peripheral blood. Spontaneous colony formation was observed in some cultures at cell concentrations of 2X 10 5 per ml and all unstimulated cultures contained many cell clusters.
CFC incidence remained high in the peripheral blood even during busulfan treatment, though a sequential analysis of individual patients undergoing chemotherapy disclosed that the incidence fell more rapidly than did total white blood cell (WBC) counts.
Patient Ma was Philadelphia chromosome negative but had all other hematologic charac-VOL. 50, NO.3, MARCH 1973 teristics of typical CML and a similar greatly elevated CFC incidence in the peripheral blood.
In partial remission with only slight elevation of WBC levels and persistence of immature cells in the circulation (patient Bo), CFC's were not detected in the peripheral blood, and the marrow incidence of both CFC's and cluster-forming cells was lower than normal. In good remission however, CFC incidence in marrow cultures was apparently normal, though spontaneous colony formation was particularly high (patient Mi, table 5).
In the acute transformation phase, in contrast with the chronic phase, colony-forming capacity of the peripheral blood was lost or greatly reduced (contrast patient In, analyzed in relapse and in acute transformation, table 5). In those patients with some detectable CFC's in the circulation, the colonies that developed on culture appeared normal in growth and differentiation and probably represented a residual population of CFC's persisting from the original clone. In 3 of 4 patients in acute transformation, cluster-forming capacity was also low or absent. A fourth patient (Mu) was analyzed in a phase of busulfan-induced aplasia and no colony or cluster formation was detectable in marrow cultures (table 5) . Subsequently, blast cells reappeared in marrow and peripheral blood and the patient became refractory to further therapy. At this stage the peripheral blast count reached 250,000/cmm and cultures of peripheral blood formed large numbers of small clusters of 3-40 cells with no colony formation evident.
Four elderly male patients with a 2-to 5-year history of monocytosis, neutrophil leukocytosis, anemia with low neutrophil alkaline-phosphate scores, and elevated serum muramidase levels were investigated for in vitro colony formation by blood or marrow cells. Clinical details of these patients have been reported and the condition characterized as a variant of CMML (16). Three of the four patients studied had a 45XO karyotype in the marrow with lack of the Y chromosome confirmed by fluorescence analysis but with a normal karyotype in phytohemagglutinin-stimulated lymphocyte cultures (16).
Cultures of peripheral blood from these CMML patients produced colonies of normal size which differentiated to granulocytes and macrophages. 
The incidence of CFC's in the peripheral blood was within the normal range in 3 of 4 patients (table 5) . Marrow samples were obtained from I patient who showed normal CFC incidence in the peripheral blood; the incidence of CFC's was elevated in the marrow. The incidence of spontaneous colonies developing in cultures of 2 X 10 5 cells/ml from this patient was the highest noted in a survey of 110 marrow samples. Cultures from the peripheral blood of patient Ha with 45XO CMML produced a greatly elevated incidence of both CFC's and cluster-forming cells on 3 separate occasions over a period of 5 months. The incidence of CFC's in the circulation of this patient varied over a nine-fold range during the period of analysis and there was an associated variation in the WBC count. Both cluster and colony incidence in this patient's peripheral blood was in the range observed in typical CML. Peripheral blood cultures from this patient also gave extremely high numbers of spontaneous colonies with (at I stage) as many colonies developing in unstimulated cultures as in those stimulated by peripheral blood feeder layers (table 5) . This patient entered an acute transformation phase 3 months after the time of in vitro analysis.
In Vitro Suiciding
As in previous studies (J 7) in vitro exposure of mouse bone marrow cells to 3H-TDR reduced the incidence of CFC's by approximately 40% (table 6) . In vitro suiciding was performed on bone marrow cells from 9 patients with no known hematologic disease or with no apparent involvement of granulopoiesis (iron-deficiency anemia, carcinoma, macrocytic anemia, infectious mononucleosis). CFC's were reduced by 39% and cluster-forming cells by 38% after preincubation with 3H-TDR. Essentially the same results were obtained with bone marrow cells from 5 patients with hematologic diseases (aplastic anemia, paroxysmal nocturnal hemoglobinuria, myelofibrosis, and polycythemia vera) associated with an increased risk of leukemia development but in whom no evidence of leukemia was apparent at bone marrow biopsy.
Where colonies or clusters were formed in peripheral blood cultures from leukemic patients, the suiciding data were essentially the same as those obtained from bone marrow cells, and the results have been pooled. On 9 occasions, peripheral blood or bone marrow cells from untreated AML patients or patients with AML in relapse were suicided in vitro and successfully grown in culture. Such cells produced only clusters on culture, but the reduction in cluster numbers after suiciding (I 7 ± 10%) was significantly lower than that in colonies or clusters after suiciding of control human marrows. In sharp contrast, in vitro suiciding of 2 marrow preparations from AML patients in complete hematologic remission reduced the in- (table 6) were essentially the same as those with untreated AML; the incidence of colonies was reduced by only 21 ± 11 % and the incidence of clusters by only 24± 12%; both reductions were significantly smaller than those obtained with control human marrow cells. Again, in 2 patients in partial or complete hematologic remission, the percentage reduction of colonies and clusters formed by marrow cells was significantly higher than with cells from untreated patients and was higher than with control marrow cells; thus the marrow cells may have been in a hyperactive, regenerative state.
Density Separation of (Fe's in Peripheral Blood and Marrow
Buoyant density separation in continuous BSA gradients was done with peripheral blood leukocytes, spleen cells, or bone marrow cells from normal subjects or patients with nonleukemic hematopoietic disorders. The density distribution profiles of CFC's from these subjects are shown in text- figure 6 , where, despite minor differences in individual profiles, considerable similarity in density distribution was evident. CFC's in peripheral blood were of intermediate density when compared with the distribution of total nucleated cells, and a major peak was always present in density region 1.067-1.069 g/cm 3 , with fewer than 0.l-5.4% of total colony-forming cells less dense than 1.062 g/cm 3 (table 7) .
In all these density separations, the distribution of cluster-forming cells was also determined and corresponded to the distribution of CFC's in the light and intermediate regions (i.e., the clusterto-colony ratio remained constant).
The buoyant density of CFC's and clusterforming cells was also determined by application of a density "cut" separation with albumin of density 1.062 g/cm 3 • In 3 marrow specimens-2 from hematologically normal subjects and 1 from a patient with anemia but with normal granulopoiesis-3.2-8.9% of CFC's were less dense than 1.062 (table 7) . The mean percent of CFC's less dense than 1.062 determined either by continuous gradients or density "cut" separation of normal and nonleukemic hematopoietic tissue was 3. allel estimates of cluster-forming cell density disclosed a similar density distribution with 2.1 % less dense than l.062 g/cm 3 • (Wa) were of markedly lighter density than corresponding cells in normal blood or marrow (text- fig. 7 ) with most CFC's less dense than 1.062 (table 7) . Density distribution profiles of CFC's were similar in both CML marrow and peripheral blood as was the CFC density profile in a further CML patient (Ta) undergoing busulfan treatment at the time of analysis.
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Density Separation of (Fe's in (ML
Continuous density separation was performed on peripheral blood and marrow from patients with CML in various clinical stages of the disease. CFC's in both marrow and peripheral blood of a typical PhI-positive CML before treatment VOL. 50, NO.3, MARCH 1973 Density separation of CFC's was also performed on patient Ma with a high WBC (280,000 per cmm), high levels of circulating CFC's, and a hema-Ph + tologic picture of typical CML but who was Phi negative. Text- figure 7 shows that the profile was similar to that seen in typical Phi-positive CML patients, with the same light density distribution.
BLOOD
Ph+
BLOOD
Ph-
BLOOD
Ph+
BLOOD BLAST CRISIS
Ph+
The 4 distribution profiles in the relapse phases of the disease all had a single peak of CFC's with a maximal incidence in the density region 1.060-1.062. This contrasted with the peak of CFC's from normal peripheral blood in density region 1.068. The percentage of total CFC's less dense than 1.062 in patients with CML is shown in table 7. In the relapse phase, 69% of CFC's were of lighter density than this, in marked contrast to 3.6% incidence of CFC's in this density region in normal or nonleukemic marrow or peripheral blood.
In the acute transformation phase of CML, density separation of peripheral blood of patient Ap disclosed a low incidence of CFC's with normal differentiation capacity in the density region occupied by CFC's in the chronic phase of the disease (text- fig. 8 ). Blast cells were distributed throughout the gradient and had no proliferative capacity in culture. Density separation was also performed on peripheral blood from patient Mu in the acute transformation phase where very extensive cluster-forming capacity was observed in culture. No CFC's showed in any density region and cluster-forming cells were present throughout the density range as a number of incompletely resolved density subpopulations. This distribution profile and percentage of cluster-forming cells less dense that 1.062 (26%) differed markedly from the distribution of either normal or CML CFC's or cluster-forming cells; it was typical of the density distribution of cluster-forming cells seen in AML peripheral blood or marrow (table 7) .
The distribution profile of CFC's from bone marrow of a CML patient in good remission (text- fig. 8 ) occupied an intermediate density region and extensively overlapped the distribution profile of CFC's in normal marrow. The magnitude of this density change between the relapse and remission phases of CML was evident when the percent of total CFC's less dense than 1.062 was considered (table  7) . In remission this value of 7% was not significantly different from normal or nonleukemic values and was in marked contrast to the 69± 11 % in the relapse or untreated phase.
Density separation studies were done on CML patient Bo in whom CFC's were no longer detectable in the peripheral blood, and leukocyte levels were only slightly elevated. This patient was considered in partial remission after busulfan treat- ment. However, the density distribution of CFC's in the marrow of this patient remained abnormal, with 76% of these cells less dense than 1.062 (table 7) despite a normal suiciding index (table 6) .
Morphology of CSF-Responsive Cells in CML
Smears for morphologic analysis were prepared from various density increments of a continuous density gradient separation of peripheral blood leukocytes from an untreated CML patient. Agar cultures of the cells in these various density increments were scored for the presence of clusters and VOL. 50, NO. 3, MARCH 1973 colonies at different stages of incubation. The peak incidence of cells proliferating in response to stimulation was noted at 5 days of culture (table 8) , and in the second to the fifth fraction, 15-59% of total nucleated cells had formed clusters of 3-100 cells by this stage. In these same fractions, 61-93% of cells were classified as myeloblasts of various sizes, with the remaining cells promyelocytes (0-2%), myelocytes (5-39%), lymphocytes (0-2%), and erythroblasts (0-2%). In the most enriched fraction, 60% of cells were able to form clusters in culture and 93% were myeloblasts. Consequently the plating efficiency of myeloblasts in this fraction was 63%, and myeloblast plating efficiency in the fractions containing >0.5% myeloblasts ranged from 7-63% with a mean of 33%, which corresponded well with the plating efficiency of 37% for the original material. The incidence of CFC's scored at 8 days of culture was highest in fractions containing 87-93% myeloblasts, though the ratio of cluster-forming cells to CFC's in these fractions was high (21-81: 1).
Density Distribution of CFe's in CMML and Myelofibrosis
The density distribution of CFC's in the peripheral blood of 2 patients with CMML was similar, despite a 200-fold difference in CFC incidence (text- fig. 9 ). Furthermore, the density profile had the same light density distribution as was obtained with CML peripheral blood cells. Application of a density" cut" separation at density 1.062 to marrow from a third patient with CMML also showed the CFC population in this condition to be of characteristically light density (table 7) . The proportion of CFC's of lighter density than 1.062 in the 3 patients was 66%, not significantly different from the 69% found in CML and markedly different from the 3.6% of the control group.
Density characterization of circulating CFC's was done on peripheral blood from a patient with a complex myeloproliferative disorder involving a history of polycythemia vera with postsplenectomy myelofibrosis. At the time of in vitro analysis, the patient's WBC was 8X 10 4 jmm 3 with a peripheral blood picture similar to that seen in untreated CML. However, the patient was Phi negative. Increased numbers of CFC's (41/2 X 10 5 cells) and of cluster-forming cells (273/2 X 10 5 cells) were in the circulation and their buoyant density distribution was similar to that seen in CML and CMML (text- fig. 9 ) with 72% of cells less dense than 1.062.
Density Distribution of CFe's and Cluster-Forming Cells in AML and SubAML
Density distribution analysis of CFC's in the marrow of 1 untreated patient with subAML (Mel) revealed that 93% of the cells were less dense than l.062 (table 7); in this respect the CFC's showed the same density abnormality as in the chronic leukemias. On induction of remission, a CFC population of normal density (4.7% less than 1.062) emerged in the marrow (table 7) , but the patient subsequently showed relapse and the incidence of CFC's in the light density region ( < 1.062) increased to 25%.
In 4 patients with untreated AMML, clusterforming cells were of light density with 79% less den~e than 1.062, which was comparable with the distribution of CFC's in patients with CML and CMML (table 7) . Continuous density gradient separation of peripheral blood from 2 patients with AMML showed a single light density population of cluster-forming cells which occupied an identical density region in both patients (text- fig.  10 ). In complete remission, density analysis showed a return of cluster-forming cell and CFC density to normal values (4.2-10% <l.062) (table 7, text- fig. 11 ).
Cluster-forming cells in marrow and peripheral blood of patients with untreated AML and promyelocytic leukemia showed a density distribution differing from normal cells or cells from other types of leukemic patients (text~fig. 11, table 7). Two patterns of density distribution were evident in AML. One, illustrated by density separation of peripheral blood of patient Beh, was heterogeneous, and cluster-forming cells were distributed throughout a wide density range with increased incidence in both high and low density regions compared with the normal density distribution profile (text- fig. 11 ). This pattern also characterized the cluster- was more homogeneous and lacked high density cluster-forming cells (text- fig. 11 ). Both the heterogeneous and homogeneous patterns of density distribution of cluster-forming cells exhibited higher than normal percentages of cells less dense than l.062. This percentage in a group of 5 patients with AML was 29%, significantly more than 3.6%
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CM.M.L. observed in the control groups but less than in AMML, CMML, and CML patients (table 7) . Two AML patients were studied in both the untreated and remission phases, and density separation was performed on the marrow cells. Patient Ch had 33% of cluster-forming cells in the marrow less dense than l.062 at first presentation, and after chemotherapy (cytosine arabinoside and rubidomycin) this percentage increased to 71 %. In remission, however, no CFC's or cluster-forming cells were present in density regions < 1.062 (table 7) . Similarly, patient McK with 29% of cluster-forming cells less dense than 1.062 in the marrow in the untreated phase subsequently entered remission and had only 0.9% of total CFC's and 0.3% of total cluster-forming cells < 1.062 upon a density "cut" separation of marrow.
DISCUSSION
The agar culture system supported the clonal proliferation of human in vitro CFC's (granulocytic progenitor cells) and their immediate progeny in a manner essentially like the well-documented behavior of comparable mouse cells. Human cultures differed, however, by exhibiting a progressive loss of many aggregates formed initially in the cultures which makes it difficult to establish the true incidence of in forming cells in human particularly important efficiency. vitro CFC's and cell populations. in determining clusterThis is cloning
As noted in (3-7) and confirmed in this study, similar differentiation occurs in clusters and colonies developing in cultures of cells from leukemic patients, even if the differentiating cells commonly have abnormalities. Formal proof of the leukemic origin of such proliferating cells has been obtained in those instances where karyotypic markers were present (7, 9, 10) . For the purposes of this discussion we can assume that most proliferating colonies and clusters in cultures of leukemic cells were derived from leukemic cells.
The analysis of size distribution patterns of clusters and colonies in leukemic cultures clearly documented a major difference between the proliferative behavior of chronic and acute granulocytic leukemic cells. Cultures of blood or bone marrow from patients with CML or CMML behaved much as did cultures of normal marrow cells. In sharp contrast, AML cells either failed to grow in vitro or produced large numbers of small aggregates which did not become larger as the cultures continued. This pattern of growth has been described by others as "abortive" colony formation (5) .
In this context, cell separation techniques and cell cycle characterization have not disclosed differences between the cluster-forming cells or CFC's in normal or leukemic human marrow, and if differences in proliferative capacity in vitro reflect differences in maturation stage in vivo, these variations must be manifest within a morphologically homogeneous compartment of cells conventionally classified as myeloblasts; more differentiated cells (promyelocytes and myelocytes) either failed to form clusters in agar culture or had a low plating efficiency.
Plating efficiency must be considered in any in vitro analytic system, particularly where conclusions on in vivo parameters are drawn from in vitro growth characteristics. When maximally stimulated, the in vitro culture system has a plating efficiency from 33-100%. This conclusion comes from the observation that, in highly enriched fractions of monkey bone marrow, I cell in 3 proliferated in response to CSF (J 1) and in this study in cultures of AML, peripheral blood and enriched density fractions of CML peripheral blood from 43-59% of cells proliferated in response to CSF.
Cell cycle analysis of CFC's or cluster-forming cells in AML marrow or peripheral blood in relapse showed these cells with reduced sensitivity to the suiciding effect of 3H_ TDR when compared with normal CFC's or cluster-forming cells. This suggests that the leukemic CSF-responsive population is either in a longer cell cycle or has an increased fraction in a noncycling Go state. This is in accord with autoradiographic studies suggesting that myeloblasts in AML have a cell cycle time of 50-60 hours in contrast to a normal myeloblast cell cycle of approximately 24 hours (19) . This approach to the in vitro analysis of responsiveness of leukemic cells to cycle-specific agents is relevant to the design of chemotherapy, particularly since in remission CFC susceptibility to 3H-TDR suiciding returns to normal values.
Major alterations in CFC-or cluster-forming cell buoyant density in acute leukemia have served as a valuable diagnostic fingerprint to identify the leukemic population, particularly during the early stages of leukemia development, during the induction of remissions, and in the early stages of relapse. The light density shift and heterogeneous density distribution of the leukemic cluster-forming cells VOL. 50, NO.3, MARCH 1973 may reflect asynchrony in nuclear-cytoplasmic maturation in which cytoplasmic differentiation precedes nuclear differentiation in the leukemic blast cell population (20) (21) (22) . Alternatively, an embryonic transformation associated with the neoplastic process may be involved. In this context, CFC's in mouse, human, or monkey fetal liver were of markedly lighter buoyant density than their adult counterparts [(23,24) ; Moore MA, Williams N, unpublished data]. Other parameters, such as cell cycle status or the influence of chemotherapy, either do not exert a sufficiently marked change in CFC density to explain the leukemic density shift or are associated with increased CFC density rather than the reverse (12, 24) .
The in vitro studies reported here show that complete remission is associated with: I) restoration of the normal incidence of both CFC's and clusterforming cells in peripheral blood and marrow; 2) return of normal in vitro proliferative and differentiation capacity; 3) restoration of normal cell cycle parameters and return of the CFC's to normal, or near-normal, buoyant density. Also, other studies have shown that, at least in some patients with pre-existing cytogenetic abnormalities, remission is also associated with restoration of normal cytogenetic status both in direct marrow preparations and meta phases obtained from in vitro colonies developing in agar culture (9, 10) . These observations strongly support the view that remission is synonomous with re-emergence of a normal stem cell population which has remained dormant during the period of relapse.
In CML or CMML there is an increased mass of differentiating cells of the granulocytic and monocytic series with characterizable chromosomal defects. Our studies have shown that in these diseases there is also hypertrophy at the level of the granulocyte-monocyte progenitor cell compartment. Cell separation and cell cycle analyses of CML and CMML marrow and peripheral blood cells showed that the CFC population is of abnormally light density and in long cell cycle or with a greater than normal population of CFC's in a non cycling state.
Complete remission in CML with disappearance of symptoms, reduction of splenomegaly, and return of all peripheral blood and marrow hema-tologic criteria to normality (14) was associated with restoration of CFC incidence, density, and cell cycle characteristics to normal. However, the PhI abnormality persists in the marrow and in the in vitro colonies (9, 24) . Our data show that the density characteristics of the CML CFC's are not influenced by the total mass of CFC's or their cell cycle status, since, in partial remission with restoration of CFC incidence and cell cycle characteristics to normal, cell density remained abnormal with associated persistence of immature cells in the circulation and a persisting abnormal erythroid-togranulocytic ratio in the marrow (see patient Bo, table 7 ).
The final evolution of CML into the acute transformation phase is associated with loss or great reduction in colony-forming capacity of peripheral blood or marrow. The characteristics of the cell population appearing in this phase were clearly comparable to those in AML, with blast cells either not proliferating or producing poorly differentiating cell clusters with cluster-forming cells having a buoyant density distribution characteristic of untreated AML.
The observation that a physical characteristic such as bouyant density can distinguish between normal and leukemic progenitor cell populations may have important therapeutic applications. For example, cell separation of marrow from leukemic patients in relapse or remission may segregate coexisting normal and leukemic stem cell and progenitor cell populations. Such a separation followed by autotransplantation of marrow fractions enriched for normal hematopoietic stem cells and depleted or devoid of the leukemic population may be a valuable adjunct to chemotherapy in the treatment of both AML and CML.
In every case examined, leukemic colony or cluster growth was stimulated by the presence of the underlayer. Even if there was only a marginal difference in the total number of aggregates, a clear difference was always seen in the range of colony or cluster sizes. There is evidence that the active factor produced by such underlayers is the specific granulocyte regulator, CSF (2) . When these data are considered in conjunction with the fact that leukemic populations contain autostimulating cells producing CSF (2), the evidence clearly indicates that most leukemic cells in humans do not exhibit autonomous growth in vitro. It can be argued that no mammalian cells are capable of autonomous growth in vitro, since all depend on metabolites for their continued survival and growth. However, in the present context "dependency" versus "automony" is being considered in relation to the growth regulator, CSF, a specific glycoprotein normally controlling granulocyte and macrophage proliferation. Thus in the terminology developed for endocrine tumorigenesis (25) , most leukemias in humans from their cultural behavior in vitro seem to fall either into the" dependent" or "responsive" categories and are not autonomous with respect to the normal growth regulator.
Characterization of CSF-responsive cells (CFC's and cluster-forming cells) by their buoyant density and cell cycle status, in addition to qualitative and quantitative information about their growth and differentiation in agar culture, provides a powerful approach to the analysis of human myeloid leukemias. The information should be of particular value in diagnosis of preleukemic or potentially leukemic hematopoietic disorders and in analysis of the competition between normal and leukemic populations during the induction of remissions and at the onset of relapses.
